ZEC has reached its most overbought reading on record, increasing the risk of a sharp 60% or more correction in the coming weeks.
You might also be interested in reading Greenwich LifeSciences gains after GP2 commercial manufacturing update.
ZEC has reached its most overbought reading on record, increasing the risk of a sharp 60% or more correction in the coming weeks.
You might also be interested in reading Greenwich LifeSciences gains after GP2 commercial manufacturing update.